MORE►
cancer drugs
Novartis CEO Vas Narasimhan, M.D. [Photo: Novartis]
Global Pharma Giant Novartis To Build Next-Gen Cancer Drug Plant in Denton, Creating North Texas Jobs
by Sandra Engelland | Feb 25, 2026
The purpose-built radiopharmaceutical site is the company’s fifth in the U.S. and the first manufacturing facility in Texas. It's expected to create new jobs in bioengineering, advanced manufacturing, quality, and operations.
by Sandra Engelland |
Dec 10, 2025
Founded on the principle that prevention is the most powerful form of cure, CPI funds innovative research aimed at intercepting cancer before it begins. The organization said it focuses on inherited cancers where a "genetic predisposition provides a clear target for early intervention—and uses this lens to unlock insights that can lead to the prevention of all cancers."
MORE►
by David Seeley |
Aug 6, 2024
A study co-led by UTSW's Jin Huk Choi, Ph.D., and Nobel Prize winner Bruce Beutler, M.D., found that targeting a gene-produced protein called ZFP574 "reduced the amount of malignant B cells by as much as 92%." Their findings could lead to new treatments for leukemias and lymphomas—and potentially other cancers, too.
MORE►
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-based Celanese Corporation has announced a collaboration with Alessa Therapeutics for developing a new oncology drug product, by utilizing the Celanese VitalDose EVA drug delivery platform. "Our new collaboration with Alessa Therapeutics underscores our commitment to optimize therapeutics through drug delivery innovation for oncology patients,” said Karen Chen, global business strategy leader for oncology at
Celanese.
MORE►
Aakha Biologics' new headquarters is at the Medical Office Building at 5680 Frisco Square Blvd. [Photo: Haven Frisco]
Aakha Biologics Relocates from BioLabs Pegasus Park to Permanent North Texas HQ in Frisco
by David Seeley | Jun 22, 2022
The startup—which discovers and develops immuno-oncology therapeutics for cancer patients—was an inaugural tenant of BioLabs Pegasus Park, a 37,000-square-foot coworking laboratory and office space that opened in March. Aakha had previously been working out of interim space managed by BioLabs at UT Southwestern.
“With the premier facility and synergies available within Pegasus Park, we moved from concept to a solid preclinical stage company in the course of one year," Aakha Founder and CEO Hemanta Baruah said.
MORE►
